Your browser doesn't support javascript.
loading
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Even, Caroline; Wang, Hung-Ming; Li, Shau-Hsuan; Ngan, Roger K-C; Dechaphunkul, Arunee; Zhang, Li; Yen, Chia-Jui; Chan, Po Chung; Chakrabandhu, Somvilai; Ma, Brigette B Y; Tanasanvimon, Suebpong; Lee, Victor H F; Lou, Pei-Jen; Li, Zujun; Spira, Alexander I; Sukari, Ammar; Guigay, Joël; McCune, Steven; Gonzalez-Maffe, Juan; Szpakowski, Sebastian; Yao, Yao; Liang, Hongzi; Mataraza, Jennifer; Séchaud, Romain; Manenti, Luigi; Lim, Darren W-T.
Afiliação
  • Even C; Medical Oncology, Gustave Roussy, Villejuif, France.
  • Wang HM; Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
  • Li SH; Department of Hematology-Oncology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Ngan RK; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.
  • Dechaphunkul A; Unit of Medical Oncology, Prince of Songkla University, Songkhla, Thailand.
  • Zhang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
  • Chan PC; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong.
  • Chakrabandhu S; Division of Radiation Oncology, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.
  • Ma BBY; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong.
  • Tanasanvimon S; Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Lee VHF; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong.
  • Lou PJ; Department of Otolaryngology, National Taiwan University Hospital, Taipei City, Taiwan.
  • Li Z; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York.
  • Spira AI; Medical Oncology, Virginia Cancer Specialists, Fairfax, Virginia.
  • Sukari A; Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan.
  • Guigay J; Medical Oncology Department, Centre Antoine Lacassagne, FHU OncoAge, Université Côte d'Azur, Nice, France.
  • McCune S; Medical Oncology, Wellstar Health System, Marietta, Georgia.
  • Gonzalez-Maffe J; Novartis Pharmaceuticals Corporation, Basel, Switzerland.
  • Szpakowski S; Oncology Translational Research, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Yao Y; Translational Clinical Oncology, Novartis Institutes for BioMedical Research, Shanghai, China.
  • Liang H; Translational Clinical Oncology, Novartis Institutes for BioMedical Research, Shanghai, China.
  • Mataraza J; Oncology Translational Research, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Séchaud R; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Manenti L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Lim DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore. darren.lim.w.t@singhealth.com.sg.
Clin Cancer Res ; 27(23): 6413-6423, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34433653
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Anticorpos Monoclonais Humanizados / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Anticorpos Monoclonais Humanizados / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França